77 related articles for article (PubMed ID: 12094969)
21. Use of benchmark dose-volume histograms for selection of the optimal technique between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in prostate cancer.
Luo C; Yang CC; Narayan S; Stern RL; Perks J; Goldberg Z; Ryu J; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1253-62. PubMed ID: 17145540
[TBL] [Abstract][Full Text] [Related]
22. Effect of prostate size and isotope selection on dosimetric quality following permanent seed implantation.
Merrick GS; Butler WM; Dorsey AT; Lief JH
Tech Urol; 2001 Sep; 7(3):233-40. PubMed ID: 11575521
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric effects of needle divergence in prostate seed implant using 125I and 103Pd radioactive seeds.
Nath S; Chen Z; Yue N; Trumpore S; Peschel R
Med Phys; 2000 May; 27(5):1058-66. PubMed ID: 10841410
[TBL] [Abstract][Full Text] [Related]
24. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
25. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
Chibani O; Williamson JF
Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
[TBL] [Abstract][Full Text] [Related]
26. A DVH-guided IMRT optimization algorithm for automatic treatment planning and adaptive radiotherapy replanning.
Zarepisheh M; Long T; Li N; Tian Z; Romeijn HE; Jia X; Jiang SB
Med Phys; 2014 Jun; 41(6):061711. PubMed ID: 24877806
[TBL] [Abstract][Full Text] [Related]
27. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M
Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469
[TBL] [Abstract][Full Text] [Related]
28. Calculating prescription doses for new sources by biologically effective dose matching.
Pritz J; Forster KM; Saini AS; Biagioli MC; Zhang GG
Brachytherapy; 2012; 11(6):521-7. PubMed ID: 22436519
[TBL] [Abstract][Full Text] [Related]
29. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
[TBL] [Abstract][Full Text] [Related]
30. Prescription dose in permanent (131)Cs seed prostate implants.
Yue N; Heron DE; Komanduri K; Huq MS
Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
[TBL] [Abstract][Full Text] [Related]
31. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
32. "SABER": A new software tool for radiotherapy treatment plan evaluation.
Zhao B; Joiner MC; Orton CG; Burmeister J
Med Phys; 2010 Nov; 37(11):5586-92. PubMed ID: 21158270
[TBL] [Abstract][Full Text] [Related]
33. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
34. IMRT: improvement in treatment planning efficiency using NTCP calculation independent of the dose-volume-histogram.
Grigorov GN; Chow JC; Grigorov L; Jiang R; Barnett RB
Med Phys; 2006 May; 33(5):1250-8. PubMed ID: 16752559
[TBL] [Abstract][Full Text] [Related]
35. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
36. Dose-shaping using targeted sparse optimization.
Sayre GA; Ruan D
Med Phys; 2013 Jul; 40(7):071711. PubMed ID: 23822415
[TBL] [Abstract][Full Text] [Related]
37. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
38. Methods, software and datasets to verify DVH calculations against analytical values: Twenty years late(r).
Nelms B; Stambaugh C; Hunt D; Tonner B; Zhang G; Feygelman V
Med Phys; 2015 Aug; 42(8):4435-48. PubMed ID: 26233174
[TBL] [Abstract][Full Text] [Related]
39. A new genetic algorithm technique in optimization of permanent 125I prostate implants.
Yang G; Reinstein LE; Pai S; Xu Z; Carroll DL
Med Phys; 1998 Dec; 25(12):2308-15. PubMed ID: 9874822
[TBL] [Abstract][Full Text] [Related]
40. Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer.
Stasi M; Munoz F; Fiorino C; Pasquino M; Baiotto B; Marini P; Malinverni G; Valdagni R; Gabriele P
Radiother Oncol; 2006 Sep; 80(3):363-70. PubMed ID: 16959344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]